- Home
- SIF vs OTLK Comparison
SIF vs OTLK Comparison
Compare SIF & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SIF | OTLK |
|---|---|---|
| Founded | 1913 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.1M | 42.3M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | SIF | OTLK |
|---|---|---|
| Price | $5.53 | $0.59 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.83 |
| AVG Volume (30 Days) | 28.6K | ★ 11.3M |
| Earning Date | 02-13-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $84,815,000.00 | $1,413,535.00 |
| Revenue This Year | N/A | $2,048.59 |
| Revenue Next Year | N/A | $142.11 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.51 | N/A |
| 52 Week Low | $2.33 | $0.50 |
| 52 Week High | $7.88 | $3.39 |
Technical Indicators
Market Signals| Indicator | SIF | OTLK |
|---|---|---|
| Relative Strength Index (RSI) | 37.58 | 25.58 |
| Support Level | $4.88 | $0.50 |
| Resistance Level | $5.99 | $2.03 |
| Average True Range (ATR) | 0.50 | 0.22 |
| MACD | -0.07 | -0.19 |
| Stochastic Oscillator | 32.55 | 5.39 |
Price Performance
Historical ComparisonAbout SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.